204 related articles for article (PubMed ID: 6803385)
1. Arachidonic acid induces human platelet-fibrin retraction: the role of platelet cyclic endoperoxides.
Di Minno G; Bertelé V; Cerletti C; de Gaetano G; Silver MJ
Thromb Res; 1982 Feb; 25(4):299-306. PubMed ID: 6803385
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors.
Rajtar G; Cerletti C; Castagnoli MN; Bertelé V; de Gaetano G
Biochem Pharmacol; 1985 Feb; 34(3):307-10. PubMed ID: 3918536
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane A2 and the endoperoxides mediate canine platelet activation.
Harris RH; Nichols R; Schmeling JW; Ramwell PW
Thromb Res; 1981 Sep; 23(6):521-32. PubMed ID: 6798707
[No Abstract] [Full Text] [Related]
4. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
Patscheke H; Stegmeier K
Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
[TBL] [Abstract][Full Text] [Related]
5. Competitive antagonism at thromboxane receptors in human platelets.
Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
Vezza R; Mezzasoma AM; Venditti G; Gresele P
Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439
[TBL] [Abstract][Full Text] [Related]
7. Manipulation of platelet aggregation by prostaglandins and their fatty acid precursors: pharmacological basis for a therapeutic approach.
Needleman P; Whitaker MO; Wyche A; Watters K; Sprecher H; Raz A
Prostaglandins; 1980 Jan; 19(1):165-81. PubMed ID: 6247744
[TBL] [Abstract][Full Text] [Related]
8. Platelet membranes, eicosanoid biosynthesis and putative endogenous calcium ionophores.
Carey F; Menashi S; Authi KS; Hack N; Lagarde M; Crawford N
Adv Exp Med Biol; 1985; 192():185-99. PubMed ID: 2422885
[No Abstract] [Full Text] [Related]
9. Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.
Brace LD; Venton DL; Le Breton GC
Am J Physiol; 1985 Jul; 249(1 Pt 2):H8-13. PubMed ID: 2409821
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin H2 directly lowers human platelet cAMP levels.
Rybicki JP; Le Breton GC
Thromb Res; 1983 Jun; 30(5):407-14. PubMed ID: 6310815
[TBL] [Abstract][Full Text] [Related]
11. "In vitro" and "ex vivo" effects of picotamide, a combined thromboxane A2-synthase inhibitor and -receptor antagonist, on human platelets.
Berrettini M; De Cunto M; Parise P; Grasselli S; Nenci GG
Eur J Clin Pharmacol; 1990; 39(5):495-500. PubMed ID: 1963845
[TBL] [Abstract][Full Text] [Related]
12. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.
Kowalska MA; Rao AK; Disa J
Biochem J; 1988 Jul; 253(1):255-62. PubMed ID: 2458717
[TBL] [Abstract][Full Text] [Related]
13. Alteration of platelet responses to metabolites of arachidonic acid by oral contraceptives.
Pan IQ; Hall ER; Wu KK
Br J Haematol; 1984 Oct; 58(2):317-23. PubMed ID: 6089860
[TBL] [Abstract][Full Text] [Related]
14. Platelet desensitization by arachidonic acid is associated with the suppression of endoperoxide/thromboxane A2 binding to the membrane receptor.
Sato T; Hashizume T; Nakao K; Akiba S; Fujii T
Biochim Biophys Acta; 1989 Aug; 992(2):168-73. PubMed ID: 2503041
[TBL] [Abstract][Full Text] [Related]
15. Platelet desensitization induced by arachidonic acid is not due to cyclo-oxygenase inactivation and involves the endoperoxide receptor.
Carmo LG; Hatmi M; Rotilio D; Vargaftig BB
Br J Pharmacol; 1985 Aug; 85(4):849-59. PubMed ID: 2994786
[TBL] [Abstract][Full Text] [Related]
16. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat.
Quilley J; McGiff JC; Nasjletti A
Br J Pharmacol; 1989 Jan; 96(1):111-6. PubMed ID: 2522332
[TBL] [Abstract][Full Text] [Related]
17. Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets.
Brace LD; Venton DL; Le Breton GC
Am J Physiol; 1985 Jul; 249(1 Pt 2):H1-7. PubMed ID: 3925795
[TBL] [Abstract][Full Text] [Related]
18. [Thrombocyte interaction with a collagen substrate: the role of thrombocyte-synthesized prostaglandin endoperoxides and thromboxane A2].
Mazurov AB; Leĭtin VL; Repin VS
Biull Eksp Biol Med; 1984 Nov; 98(11):563-6. PubMed ID: 6439262
[TBL] [Abstract][Full Text] [Related]
19. Effects of metabolized and unmetabolized arachidonate on rat platelet shape change.
Lampugnani MG; de Gaetano G
Am J Physiol; 1984 Sep; 247(3 Pt 2):H440-5. PubMed ID: 6433724
[TBL] [Abstract][Full Text] [Related]
20. A selective thromboxane synthetase inhibitor blocks the cAMP lowering activity of PGH2.
Gorman RR; Fitzpatrick FA; Miller OV
Biochem Biophys Res Commun; 1977 Nov; 79(1):305-13. PubMed ID: 200243
[No Abstract] [Full Text] [Related]
[Next] [New Search]
